AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,969 | -99.9% | 99,211 | +3.2% | 0.05% | +6.0% |
| Q3 2022 | $1,909,000 | +5354.3% | 96,153 | +5317.1% | 0.05% | +4900.0% |
| Q2 2022 | $35,000 | -22.2% | 1,775 | -22.8% | 0.00% | 0.0% |
| Q1 2022 | $45,000 | +1400.0% | 2,300 | +338.1% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 525 | +40.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 375 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 375 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $9,000 | – | 2,000 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $128,000 | +36.2% | 5,748 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $94,000 | – | 5,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |